Home›Stock Screener›Concord Biotech›Shareholding Pattern

Concord Biotech Shareholding Pattern

As of Mar 2026, Concord Biotech (CONCORDBIO) promoter holding 44.08%, FII 7.80%, DII 9.22%, public 8.09%, total shareholders 82,249. Check CONCORDBIO company valuation to track the company's total market size over time.

Promoter Holding 44.08%
FII Holding 7.80%
DII Holding 9.22%
Public Holding 8.09%
Total Shareholders 82,249
As of Mar 2026

CONCORDBIO Recent Shareholding Changes — Promoter, FII & DII

Concord Biotech promoter, FII and DII holding change from Dec 2025 to Mar 2026, FII +0.22%, DII -0.36%. Review Concord Biotech P/E valuation to evaluate earnings-based valuation against sector peers.

Promoter Holding Change
Dec 2025 to Mar 2026
No Change
FII Holding Change
Dec 2025 to Mar 2026
+0.22%
DII Holding Change
Dec 2025 to Mar 2026
-0.36%
Public Holding Change
Dec 2025 to Mar 2026
-0.02%

Concord Biotech Quarterly Shareholding Trend — Promoter, FII, DII & Public

CONCORDBIO promoter, FII, DII, public and government holding % by quarter — institutional ownership and promoter pledge trends. For live price, key ratios and the full company profile, see Concord Biotech screener.

Promoter
FII
DII
Public
Government

CONCORDBIO Shareholding Pattern Data — Quarterly History

Concord Biotech quarterly promoter, FII, DII, public holding % and total shareholders. Download as Excel or CSV.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2026 44.08% 7.80% 9.22% 0.00% 8.09% 30.81% 100.00% 82,249
Dec 2025 44.08% 7.58% 9.58% 0.00% 8.11% 30.64% 99.99% 81,815
Sept 2025 44.08% 8.03% 9.55% 0.00% 7.77% 30.56% 99.99% 82,650
Jun 2025 44.08% 9.11% 8.87% 0.00% 7.43% 30.51% 100.00% 82,045
Mar 2025 44.08% 9.35% 9.16% 0.00% 6.94% 30.47% 100.00% 81,219
Dec 2024 44.08% 8.33% 9.66% 0.00% 7.33% 30.59% 99.99% 82,004
Sept 2024 44.08% 8.10% 9.89% 0.00% 7.33% 30.61% 100.01% 84,298
Jun 2024 44.08% 7.11% 10.40% 0.00% 7.64% 30.76% 99.99% 80,737
Mar 2024 44.08% 6.48% 8.46% 0.00% 7.08% 33.90% 100.00% 83,296
Dec 2023 44.08% 0.00% 8.13% 0.00% 6.76% 41.03% 100.00% 87,486
Sept 2023 44.08% 7.30% 8.18% 0.00% 6.78% 33.66% 100.00% 100,927
Aug 2023 44.08% 0.00% 4.89% 0.00% 13.33% 37.69% 99.99% 377,572
Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2026 44.08% 7.80% 9.22% 0.00% 8.09% 30.81% 100.00% 82,249
Dec 2025 44.08% 7.58% 9.58% 0.00% 8.11% 30.64% 99.99% 81,815
Sept 2025 44.08% 8.03% 9.55% 0.00% 7.77% 30.56% 99.99% 82,650
Jun 2025 44.08% 9.11% 8.87% 0.00% 7.43% 30.51% 100.00% 82,045
Mar 2025 44.08% 9.35% 9.16% 0.00% 6.94% 30.47% 100.00% 81,219
Dec 2024 44.08% 8.33% 9.66% 0.00% 7.33% 30.59% 99.99% 82,004
Sept 2024 44.08% 8.10% 9.89% 0.00% 7.33% 30.61% 100.01% 84,298
Jun 2024 44.08% 7.11% 10.40% 0.00% 7.64% 30.76% 99.99% 80,737
Mar 2024 44.08% 6.48% 8.46% 0.00% 7.08% 33.90% 100.00% 83,296
Dec 2023 44.08% 0.00% 8.13% 0.00% 6.76% 41.03% 100.00% 87,486
Sept 2023 44.08% 7.30% 8.18% 0.00% 6.78% 33.66% 100.00% 100,927
Aug 2023 44.08% 0.00% 4.89% 0.00% 13.33% 37.69% 99.99% 377,572
Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2026 44.08% 7.80% 9.22% 0.00% 8.09% 30.81% 100.00% 82,249
Dec 2025 44.08% 7.58% 9.58% 0.00% 8.11% 30.64% 99.99% 81,815
Dec 2024 44.08% 8.33% 9.66% 0.00% 7.33% 30.59% 99.99% 82,004
Dec 2023 44.08% 0.00% 8.13% 0.00% 6.76% 41.03% 100.00% 87,486